Financial Times - Aug. 4

Aug 4 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.


- UK weighs national security concerns over Nvidia's $40bn move for Arm Link

- Sweaty Betty sold for $410 million as pandemic propels 'athleisure' further Link

- Credit Suisse to face 'tuna bonds' trial Link

- Sanofi to buy partner Translate Bio for 3.2 billion in mRNA push Link


- The future of Nvidia's planned $40 billion takeover of Arm, the British chip designer, is being considered by Prime Minister Boris Johnson's government as UK ministers take an increasingly active interest in such deals.

- Sweaty Betty, the British womenswear company, has been sold to a U.S. based shoemaker Wolverine World Wide that aims to take the upmarket brand into footwear.

- Credit Suisse will face a trial over its role in Mozambique's $2 billion "tuna bonds" scandal, a fresh blow as the bank struggles to shake off a succession of crises that have plagued the group in recent years.

- French pharmaceutical group Sanofi SA SASY.PA will acquire its partner Translate Bio TBIO.O for $3.2 billion, as it makes a big bet on the future of messenger RNA as a transformative technology for vaccines and therapeutics. (Compiled by Bengaluru newsroom)

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.